echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The first large-scale bipolar disorder gene study in Asian populations was launched

    The first large-scale bipolar disorder gene study in Asian populations was launched

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Nearly 60 percent of the world's population lives in Asian countries, but only 10 percent of genetic study participants are of
    Asian descent.
    The difference is even greater in psychiatric studies, where subjects are almost all of European ancestry, although the impact of severe mental illness is average across
    all populations.
    The lack of representation of the world's population in genetic datasets leaves out a large number of genomic variations, limiting scientists' understanding
    of the biological basis of mental disorders.

    A team of scientists from around the world is trying to solve this problem by conducting a genetic study
    of bipolar disorder in populations from India, Pakistan, Singapore, South Korea and Taiwan.
    The study, called the Asian Bipolar Disorder Gene Network (A-BIG-NET), will collect and analyze DNA, demographic, environmental and medical information
    from 27,500 patients diagnosed with mental illness and 15,000 controls.

    The project is led by the Broad Institute of Massachusetts Institute of Technology and Harvard University, the National Institute of Mental Health and Neuroscience of India (led by Biju Viswanath), the Indian Institute of Science (led by Bratati Kahali), the Singapore Institute of Mental Health (led by Jimmy Lee), Korea University School of Medicine (led by Heon-Jeong Lee), and National Taiwan University (Professor Po-Hsiu Kuo).

    。 Together, they will recruit participants, sequence genomes, analyze data, and build a network
    of rapid data sharing.

    The team hopes to uncover genetic markers for bipolar disorder, which may point to the biological causes and mechanisms
    of this disorder that affects 1-2% of the world's population.
    By focusing on Asian populations, the scientists aim to find markers that are more common in these populations than in others, potentially highlighting the genetic roots
    of the disease shared by other populations around the world.
    A better understanding of the causes of bipolar disorder from this research may one day lead to new and better treatments
    .

    "There hasn't been any large-scale genetic studies of bipolar disorder in Asian populations," said Hailiang Huang, director of the Stanley Global Asia Program at Broad University's Stanley Center for Psychiatric Research, who is also an assistant professor
    at Massachusetts General Hospital and Harvard Medical School.
    "If this continues, we risk that therapeutic innovations may exclude a large portion
    of the global population that is underrepresented in psychiatric genetics.
    " This is a major unresolved challenge
    for all of the world, including South and East Asians.

    This new project expands on Stanley Global, a Stanley Center initiative in 2014 to diversify genetic research and include underrepresented populations around the world
    .
    Stanley Global launched a project called NeuroGAP-Psychosis in 2018 to study the genetics of schizophrenia in four African countries, while another project called NeuroMex is conducting the same in
    Mexico.
    NeuroDev is studying neurodevelopmental differences
    between Kenyans and South Africans.

    "Studies like A-BIG-NET have the potential to uncover rare mutation risk genes, which should have a significant impact on understanding the mechanisms of bipolar disorder, much as the SCHEMA study did for schizophrenia
    .
    " Because Asian populations have different genetic variants, including them in A-BIG-NET will enhance the diversity and richness of gene discovery for bipolar disorder," said
    Morgan Sheng, co-director of the Stanley Center.

    Global partnership

    A-BIG-NET was inspired by NeuroGAP-Psychosis and NeuroMex to expand this genetics research to Asian countries
    .
    While Stanley Global has previously sequenced genomic samples from East Asian populations, A-BIG-NET expanded the work to include bipolar disorder and will study larger cohorts
    .
    It will also be the first known large-scale study to explore the genetics of bipolar disorder in a South Asian country and will build on the latest findings from the Stanley Center, including the first strong genetic signal
    for bipolar disorder.

    "This study will be an important step in increasing research equity, particularly in the field of psychiatric genetics," said
    Biju Viswanath, professor of psychiatry at NIMHANS India and head of the Indian division of the study.
    Wiswanath founded the Indian Clinical Association of Mental Illness and Genetics (IC-MAGIC), which conducts large-scale genetic research
    on mental health.
    Participants from India will be the largest group of
    the study.

    "The project will allow for advanced training in psychiatric genetics and attract more researchers and participants
    .
    " This will allow for more community participation and expand research capacity
    in the region.
    We will be able to understand these complex diseases globally and, more importantly, locally," said
    Sanjeev Jain, NIMHANS professor and senior co-investigator of the study.

    About one-third of A-BIG-NET gene samples will be sequenced by the genomic platform in Broad, and the rest will be analyzed
    in their home countries.
    The scientists will use a recently developed sequencing technique called the mixed genome exome (BGE), which can deeply sequence the exome (2% of the protein in human DNA) and decode the rest of the genome more broadly
    .
    This approach aims to increase the chances of discovering new genetic variants from global samples in a cost-effective way, allowing large numbers of samples to be sequenced
    .

    The team will publicly share A-BIG-NET data
    through the National Mental Health Data Archive Institute (NDA) and the biphasic Exomes browser.
    They will also contribute their data to the Psychiatric Genomics Alliance Bipolar Disorder Working Group and the Bipolar Disorder Sequencing Project, which will allow them to compare
    their results with those of other studies focused on European populations.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.